Skip to main content

Advertisement

Log in

Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Purpose

To assess axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.

Materials and methods

Prospective study was conducted on 65 enlarged axillary lymph nodes in 34 consecutive female patients (28–64 years: mean 51 years) with breast cancer. They underwent T2-weighted, dynamic contrast-enhanced and diffusion-weighted MR imaging of the breast and axilla using a single-shot echo-planar imaging with a b factor of 0500 and 1000 s/mm2. Morphologic and quantitative parameters included ADC value of the axillary lymph node which was calculated and correlated with surgical findings.

Results

The mean ADC value of metastatic axillary lymph nodes was 1.08 ± 0.21 × 10−3 mm2/s and of benign lymph nodes was 1.58 ± 0.14 × 10−3 mm2/s. There was statistically difference in mean ADC values between metastatic and of benign axillary lymph nodes (P = 0.001). Metastatic nodes were associated with low ADC ≤ 1.3 (OR = 8.0), short axis/long axis (TS/LS) > 0.6 (OR = 7.0) and absent hilum (OR = 6.21). When ADC of 1.3 × 10−3 mm2/s was used as a threshold value for differentiating metastatic from benign axillary lymph nodes, the best result was obtained with an accuracy of 95.6 %, sensitivity of 93 %, specificity of 100 %, positive predictive value of 100 %, negative predictive value of 87.5 % and area under the curve of 0.974. Multivariate model involving combined ADC value and TS/LS improved the diagnostic performance of MR imaging with AUC of 1.00.

Conclusion

We concluded that combination of diffusion-weighted MR imaging with morphological and dynamic MR imaging findings helps for differentiation of metastatic from benign axillary lymph nodes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

ADC:

Apparent diffusion coefficient

AUC:

Area under the curve

NPV:

Negative predictive value

ORs:

Odds ratios

PPV:

Positive predictive value

ROC:

Receiver operating characteristic

TIC:

Time–intensity curves

TS/LS:

Short axis to long axis

References

  1. Dull BZ, Neuman HB. Management of the axilla. Surg Clin North Am. 2013;93:429–44.

    Article  Google Scholar 

  2. Thompson AM. New standards of care in the management of the axilla. Curr Opin Oncol. 2012;24:605–11.

    Article  PubMed  Google Scholar 

  3. Rahbar H, Partridge S, Javid S, Lehman C. Imaging axillary lymph nodes in patients with newly diagnosed breast cancer. Curr Probl Diagn Radiol. 2012;41:149–58.

    Article  PubMed  Google Scholar 

  4. Cools-Lartigue J, Meterissian S. Accuracy of axillary ultrasound in the diagnosis of nodal metastasis in invasive breast cancer: a review. World J Surg. 2012;36:46–54.

    Article  PubMed  Google Scholar 

  5. Tsai WC, Lin CK, Wei HK, Yu BL, Hung CF, Cheng SH, Chen CM. Sonographic elastography improves the sensitivity and specificity of axilla sampling in breast cancer: a prospective study. Ultrasound Med Biol. 2013;39:941–9.

    Article  PubMed  Google Scholar 

  6. Song SE, Seo BK, Lee SH, Yie A, Lee KY, Cho KR, Woo H, Cha SH, Kim B. Classification of metastatic versus non-metastatic axillary nodes in breast cancer patients: value of cortex-hilum area ratio with ultrasound. J Breast Cancer. 2012;15:65–70.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Nasu Y, Shikishima H, Miyasaka Y, Nakakubo Y, Ichinokawa K, Kaneko T. A study of the assessment of axillary lymph nodes before surgery for breast cancer using multidetector-row computed tomography. Surg Today. 2010;40:1023–6.

    Article  PubMed  Google Scholar 

  8. Keam B, Im S, Koh Y, Han S, Oh D, Cho N, Kim JH, Han W, Kang KW, Moon WK, Kim TY, Park IA, Noh DY, Chung JK, Bang YJ. Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy. Breast Cancer. 2013;20:167–73.

    Article  PubMed  Google Scholar 

  9. Scaranelo AM, Eiada R, Jacks LM, Kulkarni SR, Crystal P. Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability. Radiology. 2012;262:425–34.

    Article  PubMed  Google Scholar 

  10. Ecanow J, Abe H, Newstead G, Ecanow D, Jeske J. Axillary staging of breast cancer: what the radiologist should know. Radiographics. 2013;33:1589–612.

    Article  PubMed  Google Scholar 

  11. Loiselle C, Eby P, Peacock S, Kim J, Lehman C. Dynamic contrast-enhanced magnetic resonance imaging and invasive breast cancer: primary lesion kinetics correlated with axillary lymph node extracapsular extension. J Magn Reson Imaging. 2011;33:96–101.

    Article  PubMed  Google Scholar 

  12. Mortellaro V, Marshall J, Singer L, Hochwald S, Chang M, Copeland E, Grobmyer SR. Magnetic resonance imaging for axillary staging in patients with breast cancer. J Magn Reson Imaging. 2009;30:309–12.

    Article  PubMed  Google Scholar 

  13. Seenu V, Kumar M, Sharma U, Gupta S, Mehta S, Jagannathan N. Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer. Magn Reson Imaging. 2005;23:1005–10.

    Article  PubMed  Google Scholar 

  14. Korteweg MA, Zwanenburg JJ, Hoogduin JM, van den Bosch MA, van Diest PJ, van Hillegersberg R, Eijkemans MJ, Mali WP, Luijten PR, Veldhuis WB. Dissected sentinel lymph nodes of breast cancer patients: characterization with high-spatial-resolution 7-T MR imaging. Radiology. 2011;261:127–35.

    Article  PubMed  Google Scholar 

  15. Schipper RJ, Smidt ML, van Roozendaal LM, Castro CJ, de Vries B, Heuts EM, Keymeulen KB, Wildberger JE, Lobbes MB, Beets-Tan RG. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging. Invest Radiol. 2013;48:134–9.

    Article  PubMed  Google Scholar 

  16. Mullen R, Purdie CA, Jordan LB, McLean D, Whelehan P, Vinnicombe S, Brown DC, Evans A. Can additional histopathological examination of ultrasound-guided axillary lymph node core biopsies improve preoperative diagnosis of primary breast cancer nodal metastasis? Clin Radiol. 2013;68:704–7.

    Article  CAS  PubMed  Google Scholar 

  17. Brandão AC, Lehman CD, Partridge SC. Breast magnetic resonance imaging: diffusion-weighted imaging. Magn Reson Imaging Clin North Am. 2013;21:321–36.

    Article  Google Scholar 

  18. Thomassin-Naggara I, De Bazelaire C, Chopier J, Bazot M, Marsault C, Trop I. Diffusion-weighted MR imaging of the breast: advantages and pitfalls. Eur J Radiol. 2013;82:435–43.

    Article  CAS  PubMed  Google Scholar 

  19. Razek AA, Gaballa G, Denewer A, Tawakol I. Diffusion weighted MR imaging of the breast. Acad Radiol. 2010;17:382–6.

    Article  PubMed  Google Scholar 

  20. Tan SL, Rahmat K, Rozalli F, Mohd-Shah N, Aziz Y, Yip C, Vijayananthan A, Ng KH. Differentiation between benign and malignant breast lesions using quantitative diffusion weighted sequence on 3 T MRI. Clin Radiol. 2014;69:63–71.

    Article  CAS  PubMed  Google Scholar 

  21. El Khouli R, Jacobs M, Mezban S, Huang P, Kamel I, Macura K, Bluemke DA. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology. 2010;256:64–73.

    Article  Google Scholar 

  22. Parsian S, Rahbar H, Allison KH, Demartini WB, Olson ML, Lehman CD, Partridge SC. Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging. Radiology. 2012;265:696–706.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Heusner TA, Kuemmel S, Koeninger A, Hamami ME, Hahn S, Quinsten A, Bockisch A, Forsting M, Lauenstein T, Antoch G, Stahl A. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging. 2010;37:1077–86.

    Article  PubMed  Google Scholar 

  24. Razek AA, Gaballa G, Denewer A, Nada N. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed. 2010;23:619–23.

    Article  PubMed  Google Scholar 

  25. Razek AA, Elkammary S, Elmorsy A, Elshafey M, Elhadedy T. Characterization of mediastinal lymphadenopathy with diffusion-weighted imaging. Magn Reson Imaging. 2011;29:167–72.

    Article  PubMed  Google Scholar 

  26. Cheng J, Wang Y, Deng J, McCarthy R, Wang G, Wang H, Ye Y. Discrimination of metastatic lymph nodes in patients with gastric carcinoma using diffusion-weighted imaging. J Magn Reson Imaging. 2013;37:1436–44.

    Article  PubMed  Google Scholar 

  27. Razek AAA, Soliman NY, Elkhammary S, Alsharaway MK, Tawfik A. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol. 2006;16:1468–77.

    Article  PubMed  Google Scholar 

  28. Mir N, Sohaib SA, Collins D, Koh DM. Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis. J Med Imaging Radiat Oncol. 2010;54:358–64.

    Article  CAS  PubMed  Google Scholar 

  29. Luo N, Su D, Jin G, Liu L, Zhu X, Xie D, Liu Y. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients. Magn Reson Imaging. 2013;38:824–8.

    Article  Google Scholar 

  30. Kamitani T, Hatakenaka M, Yabuuchi H, Matsuo Y, Fujita N, Jinnouchi M, Nagao M, Shirahane K, Tokunaga E, Honda H. Detection of axillary node metastasis using diffusion-weighted MRI in breast cancer. Clin Imaging. 2013;37:56–61.

    Article  PubMed  Google Scholar 

  31. Fornasa F, Nesoti VM, Bovo C, Bonavina GM. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer. J Magn Reson Imaging. 2012;36:858–64.

    Article  PubMed  Google Scholar 

  32. He N, Xie C, Wei W, Pan C, Wang W, Lv N, Wu P, et al. A new, preoperative, MRI-based scoring system for diagnosing malignant axillary lymph nodes in women evaluated for breast cancer. Eur J Radiol. 2012;81:2602–12.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed Abdel Khalek Abdel Razek.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Razek, A.A.K.A., Lattif, M.A., Denewer, A. et al. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging. Breast Cancer 23, 525–532 (2016). https://doi.org/10.1007/s12282-015-0598-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-015-0598-7

Keywords

Navigation